Form 4: Vicarious Surgical Inc. Executive Acquires Stock Options

John Mazzola, Chief Operating Officer of Vicarious Surgical Inc., reports the acquisition of stock options.

Summary

• On June 17, 2024, John Mazzola, the Chief Operating Officer of Vicarious Surgical Inc., acquired 6,385 stock options with an exercise price of $6.86.
• These options vest in equal monthly installments over 48 months, starting June 17, 2024, contingent upon Mr. Mazzola's continued service.
• Following this transaction, Mr. Mazzola directly owns 6,385 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither overtly positive nor negative.

Positives

• The acquisition of stock options by a key executive like the COO can be seen as a positive sign, aligning their interests with the company's long-term success.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects standard practices for incentivizing key personnel.

Comparison to Industry Standards

• Stock option grants are a common component of executive compensation packages in the technology and medical device industries.
• Companies like Intuitive Surgical and Stryker also utilize stock options to align executive incentives with shareholder value.
• The vesting schedule of 48 months is a typical vesting period for such grants.

Stakeholder Impact

• The stock option grant aligns the COO's interests with those of the shareholders, potentially incentivizing actions that increase shareholder value.

Key Dates